Physician

Mark Rowand, MD

According to 2025 Medicare claims, Mark Rowand, MD (NPI: 1104948702) practices family practice in the York-Hanover, PA market, with the plurality of this provider's patient population coming from York, PA. This provider's primary affiliated billing organization is DALLASTOWN MEDICAL ASSOCIATES LLP (NPI: 1003881186; TIN: 232109447) and primary practice location at 17313-9220. Rowand is affiliated with the WellSpan Population Health Services (ACO ID: A2500), participating under the MSSP model.

Rowand's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 459 traditional Medicare patients, billed 14,485 HCPCS/CPT codes, and received $315,011 in Medicare payments. The top billing code was 99213 (Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more). Part D data shows 12,188 prescription claims across 859 beneficiaries totaling $1,402,142 in drug costs, led by Eliquis (Apixaban). DME data shows 319 claims. Open Payments data shows 56 records totaling $1,083. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $137,881 to $315,011. Similarly, Part D prescription costs have moved sharply higher in recent years, from $238,542 to $1,402,142. In contrast, DME billing represents a smaller volume and moved from a lower plateau to a higher plateau, from $12,295 to $26,921.